Analyst Research Report Snapshot

Title:

ASSURA GROUP - CHECK STRATEGIC HEALTH

Price:

$10.00

Provider:

Edison Investment Research

Date:

03 Jul 2009

Pages:

2

Type:

AcrobatPDF

Companies referenced:

AGRP.L

Available for Immediate Download
Summary:

Assura has reported full year results and reported on its progress in undertaking a strategic transition that will take several years to come to fruition. The move from a £354m asset property business with £22m rental income to an NHS primary care service provider is not straightforward. The GP provider company (GPCo) model has given 55 actual or potential contracts. Pharmacy will grow from 38 to 42 stores and could become profitable in this financial year. However, NHS services run on narrow, volume-dependant margins and Assura has high overheads: £7m for medical and £11m for pharmacy. The shares are at a discount to the 67p NAV. FOR MORE INFORMATION ON THE ATTACHED RESEARCH PLEASE CALL 020 3077 5713 OR EMAIL RESEARCH@EDISONINVESTMENTRESEARCH.CO.UK OR VISIT WWW.EDISONINVESTMENTRESEARCH.CO.UK

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.